Table 3.

Long-Term Outcomes of CDH Survivors by level of pulmonary support on Day of Life 30 (Birth Year 1995–2006, N=151). One hundred and five (70%) patients had long-term clinical follow-up. Median age at five-year clinic appointment was 5.10 years (IQR: 4.73–5.8 years).

Birth Year 1995–2006	Invasive or Noninvasive Support (n=66) N (%)	Room Air (n=85) N (%)	p-value
No Long-term Follow-up	17 (25.8)	29 (34.1)	.29
5-Year Clinical Outcomes of Followed Cohort (At least 3 years of follow-up):
Pulmonary Outcomes
Inhaler Use	34/49 (69.4)	22/56 (39.3)	.003*
Inhaled Steroids Use	23/49 (46.9)	13/56 (23.2)	.01*
Diagnosis of Asthma	28/49 (57.1)	17/56 (30.4)	.01*
Developmental Outcomes
Referred for Developmental Therapy	27/49 (55.1)	15/56 (26.8)	.005*
--------------------------------------------	------------	------------	------------
• Motor	14/27 (51.9)	7/15 (46.7)
• Verbal	3/27 (11.1)	3/15 (20.0)	.82
• Both	10/27 (37.0)	5/15 (33.3)
5-Year Ventilation/Perfusion (V/Q) Scan (At least 3 years of age):
V/Q Scan Performed	33/49 (67.3)	37/56 (66.1)	1.0
Any Ipsilateral V/Q Mismatch:
V/Q Ratio ≥ 1.2
Yes	29 (87.9)	28 (75.7)	.23
No	4 (12.1)	9 (24.3)
Severe Ipsilateral V/Q Mismatch:
V/Q Ratio ≥ 1.44
Yes	20 (60.6)	10 (27.0)	.008*
No	13 (39.4)	27 (73.0)